No Data
No Data
Phathom Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.
Phathom Pharmaceuticals Analyst Ratings
Express News | Phathom Pharmaceuticals, Inc. : H.c. Wainwright Cuts Target Price to $20 From $28
Express News | Phathom Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Phathom Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Phathom Pharmaceuticals Stock Drops 23% As Loss Widens In Q1